An alternate insulin-like growth factor I receptor signaling pathway for the progression of endothelial-mesenchymal transition

Bioscience Hypotheses

Volumn 1, Issue 6, 2008, Pages 312-318

  Arciniegas, Enrique ^a   Candelle, Daniel ^b  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

^b Universidad Nacional Experimental Francisco de Miranda   (Venezuela)

Author keywords

Cell cell contacts; Endothelial mesenchymal transition; Microtubules

Indexed keywords

BETA CATENIN; CYTOKINE; GROWTH FACTOR; PROTEINASE; SOMATOMEDIN C RECEPTOR; TYROSINE; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CELL TRANSFORMATION; CYTOSKELETON; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC REGULATION; HUMAN; MICROTUBULE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 57049134610     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2008.07.012     Document Type: Article

References (74)

1. Arciniegas E., Frid M.G., Douglas I.S., and Stenmark K.R. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 293 (2007) L1-L8
2. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A., McMullen J., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13 (2007) 952-961
3. Mironov V., Visconti R.P., and Markwald R.R. On the role of shear stress in cardiogenesis. Endothelium 12 (2005) 259-261
4. Zeisberg E.M., Potenta S., Xie L., Zeisberg M., and Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67 (2007) 10123-10181
5. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7 (2006) 131-142
6. Baum B., Settleman J., and Quinlan M.P. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19 (2008) 294-308
7. Liebner S., Cavallaro U., and Dejana E. The multiple languages of endothelial cell-to-cell communication. Arterioscler Thromb Vasc Biol 26 (2006) 1431-1438
8. van Buul J.D., Anthony E.C., Fernandez-Borja M., Burridge K., and Hordijk P.L. Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating β-catenin tyrosine phosphorylation. J Biol Chem 280 (2005) 21129-21136
9. Frid M.G., Kale V.A., and Stenmark K.R. Mature vascular endothelium can give rise to smooth muscle cells via endothelial mesenchymal transdifferentiation: in vitro analysis. Circ Res 90 (2002) 1189-1196
10. Liebner S., Catellino A., Gallini R., Rudini N., Iurlaro M., Piccolo S., et al. β-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol 166 (2004) 359-367
11. Arciniegas E., Neves Y.C., and Carrillo L.M. Potential role for insulin-like growth factor II and vitronectin in the endothelial-mesenchymal transition process. Differentiation 74 (2006) 277-292
12. Le Roith D., and Roberts Jr. C.T. The insulin-like growth factor system and cancer. Cancer Lett 195 (2003) 127-137
13. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Cancer 4 (2004) 507-518
14. Denley A., Cosgrove L.J., Booker G.W., Wallace J.C., and Forbes B.E. Molecular interactions of the IGF system. Cytokine Growth Factor Rev 16 (2005) 421-439
15. Chao W., and D'Amore P.A. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 19 (2008) 111-120
16. Zaina S., and Nilsson J. Insulin-like growth factor II and its receptors in atherosclerosis and in conditions predisposing to atherosclerosis. Curr Opin Lipidol 14 (2003) 483-489
17. Opgaard O.S., and Wang P.H. IGF-I is matter of heart. Growth Horm IGF Res 15 (2005) 89-94
18. Cheng J., and Du J. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor I receptor. Arterioscler Thromb Vasc Biol 27 (2007) 1744-1751
19. Louvi A., Accili D., and Efstratiadis A. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189 (1997) 33-48
20. Scanes C.G., Thommes R.C., Radecki S.V., Buonomo F.C., and Woods J.E. Ontogenic changes in the circulating concentrations of insulin-like growth factor (IGF)-I, IGF-II, and IGF-binding proteins in the chicken embryo. Gen Comp Endocrinol 106 (1997) 265-270
21. Allan G.J., Zannoni A., McKinnell I., Otto W., Holzenberger M., Flint D.J., et al. Major components of the insulin-like growth factor axis are expressed early in chicken embryogenesis, with IGF binding protein (IGFBP) expression subject to regulation by sonic hedgehog. Anat Embryol 207 (2003) 73-84
22. McMurtry J.P., Rosebrough R.W., Brocht D.M., Francis G.L., Upton Z., and Phelps P. Assessment of developmental changes in chicken and turkey insulin-like growth factor-II by homologous radioimmunoassay. J Endocrinol 157 (1998) 463-473
23. Yee D. Targeting insulin-like growth factor pathways. Br J Cancer 94 (2006) 465-468
24. Baserga R., Peruzzi F., and Reiss K. The IGF-I receptor in cancer biology. Int J Cancer 107 (2003) 873-877
25. Valentinis B., and Baserga R. IGF-I receptor signalling in transformation and differentiation. J Clin Pathol Mol Pathol 54 (2001) 133-137
26. Wu Y., Karas M., Dupont J., Zhao H., Toyoshima Y., and Le Roith D. Multiple signaling pathways are involved in the regulation of IGF-I receptor inhibition of PTEN-enhanced apoptosis. Growth Horm IGF Res 14 (2004) 52-58
27. Riedemann J., and Macaulay V.M. IGFIR signalling and its inhibition. Endocr Relat Cancer 13 (2006) S33-S43
28. Julien S., Puig I., Caretti E., Bonaventure J., Nelles L., Van Roy F., et al. Activation of NF-kappaB by Akt upregulates snail expression and induces epithelium mesenchyme transition. Oncogene 26 (2007) 7445-7456
29. Ryan P.D., and Goss P.D. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist 13 (2008) 16-24
30. 3 integrin signaling. Carcinogenesis 27 (2006) 962-971
31. Mauro L., and Surmacz E. IGF-I receptor, cell-cell adhesion, tumour development and progression. J Mol Histol 35 (2004) 247-253
32. Mauro L., Salerno M., Morelli C., Boterberg T., Bracke M.E., and Surmacz E. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression. J Cell Physiol 194 (2002) 108-116
33. Morali O.G., Delmas V., Moore R., Jeanney C., Thiery J.P., and Larue L. IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20 (2001) 4942-4950
34. Canonici A., Steelent W., Rigot V., Khomitch-Baud A., Boutaghou-Cherid, Bruyneel E., et al. Insulin-like growth factor I receptor, E-cadherin and αv integrin form a dynamic complex under the control of α-catenin. Int J Cancer 122 (2008) 572-582
35. Allison A.S., McIntyre M.A., McArdle C., and Habib F.K. The insulin-like growth factor type I receptor and colorectal neoplasia: insights into invasion. Hum Pathol 38 (2007) 1590-1602
36. Reik W., Constancia M., Dean W., Davies K., Bowden L., Murrel A., et al. IGF2 imprinting in development and disease. Int J Dev Biol 44 (2000) 145-150
37. Baserga R. The contradictions of the insulin-like growth factor I receptor. Oncogene 19 (2000) 5574-5581
38. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7 (1995) 619-627
39. Conacci-Sorrel M., Zhurinsky J., and Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109 (2002) 987-991
40. Chen X., and Gumbiner B.M. Crosstalk between different adhesion molecules. Curr Opin Cell Biol 18 (2006) 572-578
41. Chen J., Wu A., Sun H., Drakas R., Garofalo C., Cascio S., et al. Functional significance of type I insulin-like growth factor mediated nuclear translocation of the insulin receptor substrate-1 and β-catenin. J Biol Chem 280 (2005) 29912-29920
42. Kalliman P., Canicio J., Testar J., Palacin M., and Zorzano A. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-κB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J Biol Chem 274 (1999) 17437-17444
43. Kwon Y.W., Jang E.R., Lee Y.M., Kim Y.S., Kwon K.S., Jang H.S., et al. Insulin-like growth factor-II induces interleukin-6 expression via NF-κB activation in psoriasis. Biochem Biophys Res Commun 278 (2000) 312-317
44. Kim H.Y., Litzenburger B.C., Cui X., Delgado D.A., Grabiner B.C., Lin X., et al. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-κB and snail. Mol Cell Biol 27 (2007) 3165-3175
45. Huber M.A., Azoitel N., Baumann B., Grünert S., Sommer A., Pehamberger H., et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114 (2004) 569-581
46. Chua H.L., Bhat-Nakshatri P., Clare S.E., Morimiya A., Badve S., and Nakshatri H. NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26 (2007) 711-724
47. Arciniegas E., Carrillo L.M., De Sanctis J.B., and Candelle D. Possible role of NF-κB in the embryonic vascular remodeling and the endothelial-mesenchymal transition process. Cell Adhesion Migration 2 (2008) 1-13
48. Stehbens S.J., Paterson A.D., Crampton M.S., Shewan A.M., Ferguson C., Akhmanova A., et al. Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts. J Cell Sci 119 (2006) 1801-1811
49. Chang L., and Goldman R.D. Intermediate filaments mediate cytoskeletal crosstalk. Mol Cell Biol 5 (2004) 601-613
50. Stamenovic D. Effects of cytoskeletal prestress on cell rheological behavior. Acta Biomater 1 (2005) 255-262
51. Galbraith C.G., Skalah R., and Chien S. Shear stress induces spatial reorganization of the endothelial cell cytoskeleton. Cell Motil Cytoskeleton 40 (1997) 317-330
52. Mitchison T., and Kirschner M. Dynamic instability of microtubule growth. Nature 312 (1984) 237-242
53. Honore S., Pasquier E., and Braguer D. Understanding microtubule dynamics for improved cancer therapy. Cell Mol Life Sci 62 (2005) 3039-3056
54. Akhmanova A., and Steinmetz M.O. Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat Rev 9 (2008) 309-322
55. Kapeller R., Toker A., Cantley L.C., and Carpenter C.L. Phosphoinositide 3-kinase binds constitutively to α/β-tubulin and binds to γ-tubulin in response to insulin. J Biol Chem 270 (1995) 25985-25991
56. Reszka A.A., Seger R., Diltz C.D., Krebs E.G., and Fischer E.H. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci U S A 92 (1995) 8881-8885
57. Burgess S.A., Walker M.L., Sakakibara H., Knight P.J., and Oiwa K. Dynein structure and power stroke. Nature 421 (2003) 715-718
58. Mizuno N., Narita A., Kon T., Sutoh K., and Kikkawa M. Three-dimensional structure of cytoplasmic dynein bound to microtubules. Proc Natl Acad Sci U S A 104 (2007) 20832-20837
59. Ligon L.A., Karki S., Tokito M., and Holzbaur E.L.F. Dynein binds to β-catenin and may tether microtubules at adherens junctions. Nat Cell Biol 3 (2001) 913-917
60. Ligon L.A., and Holzbaur E.L.F. Microtubules tethered at epithelial cell junctions by dynein facilitate efficient junction assembly. Traffic 8 (2007) 808-819
61. Rossette C., and Karin M. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-κB. J Cell Biochem 128 (1995) 1111-1119
62. Crépieux P., Kwon H., Leclerc N., Spencer W., Richard S., Lin R., et al. IκBα physically interacts with a cytoskeleton-associated protein through its signal response domain. Mol Cell Biol 17 (1997) 7375-7385
63. Bourgarel-Rey V., Vallee S., Rimet O., Champion S., Braguer D., Desobry A., et al. Involvement of nuclear factor κB in c-Myc induction by tubulin polymerization inhibitors. Mol Pharmacol 59 (2001) 1165-1170
64. Mistry P., Deacon K., Mistry S., Blank J., and Patel R. NF-κB promotes survival during mitotic cell cycle arrest. J Biol Chem 279 (2004) 1482-1490
65. Mikenberg I., Widera D., Kaus A., Kaltschmidt B., and Kaltschmidt C. Transcription factor NF-κB is transported to the nucleus via cytoplasmic dynein/dynactin motor complex in hippocampal neurons. PloS ONE 2 (2007) e589
66. Kuphal S., Poser I., Jobin C., Hellerbrand C., and Bosserhoff A.K. Loss of E-cadherin leads to upregulation of NF-κB activity in malignant melanoma. Oncogene 23 (2004) 8509-8519
67. Lee T.-Y.J., and Gotlieb A.I. Microfilaments and microtubules maintain endothelial integrity. Microsc Res Tech 60 (2003) 115-127
68. Tzima E., Irani-Tehrani M., Kiosses W.B., Dejana E., Schultz D.A., Engelhardt B., et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437 (2005) 426-431
69. Yamashita H., Ichijo H., Grimsby S., Morén A., Dijke P.T., and Miyazono K. Endoglin forms a heterodimeric complex with the signaling receptors for transforming growth factor-β*. J Biol Chem 269 (1994) 1995-2001
70. Bazzoni G., and Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84 (2004) 869-901
71. Meng Q.J., Lux A., Holloschi A., Li J., Hughes J., Foerg T., et al. Identification of Tctex2β, a novel dynein light chain family member that interacts with different transforming growth factor-β receptors. J Biol Chem 281 (2006) 37069-37080
72. Masszi A., Fan L., Rosivall L.M., McCulloch C.A., Rotstein L., Mucsi I., et al. Integrity of cell-cell contacts is a critical regulator of TGF-β1 induced epithelial-to-myofibroblast transition. Role for β-catenin. Am J Pathol 165 (2004) 1955-1967
73. Arciniegas E., Sutton A.B., Allen T.D., and Schor A.M. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 103 (1992) 521-529
74. Ishisaki A., Hayashi H., Li A.J., and Imamura T. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem 278 (2003) 1303-1309